Advertisement
BCYC vs PCVX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and PCVX is a Hold.
BCYC's RSI Indicator recovers from oversold territory
The RSI Indicator for BCYC moved out of oversold territory on October 05, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 48 similar instances when the indicator left oversold territory. In 40 of the 48 cases the stock moved higher. This puts the odds of a move higher at 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 69 cases where BCYC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for BCYC just turned positive on October 22, 2026. Looking at past instances where BCYC's MACD turned positive, the stock continued to rise in 34 of 47 cases over the following month. The odds of a continued upward trend are 72%.
Following a +4.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where BCYC advanced for three days, in 188 of 247 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BCYC as a result. In 75 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
BCYC moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCYC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
BCYC broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BCYC entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.499) is normal, around the industry mean (2.973). P/E Ratio (-1.333) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (4.136) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. BCYC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCYC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PCVX in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 05, 2026
PCVX broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 44 similar instances where the stock broke above the upper band. In 37 of the 44 cases the stock fell afterwards. This puts the odds of success at 84%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for PCVX moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 28 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.
The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PCVX as a result. In 56 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
The Moving Average Convergence Divergence Histogram (MACD) for PCVX turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 33 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCVX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for PCVX entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
PCVX moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PCVX crossed bullishly above the 50-day moving average on October 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +4.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where PCVX advanced for three days, in 225 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.391) is normal, around the industry mean (2.973). P/E Ratio (-8.237) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. PCVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
BCYC | PCVX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 84 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 37 Fair valued | 21 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 72 | |
SMR RATING 1..100 | 97 | 96 | |
PRICE GROWTH RATING 1..100 | 76 | 40 | |
P/E GROWTH RATING 1..100 | 27 | 58 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PCVX's Valuation (21) in the null industry is in the same range as BCYC (37). This means that PCVX’s stock grew similarly to BCYC’s over the last 12 months.
PCVX's Profit vs Risk Rating (72) in the null industry is in the same range as BCYC (100). This means that PCVX’s stock grew similarly to BCYC’s over the last 12 months.
PCVX's SMR Rating (96) in the null industry is in the same range as BCYC (97). This means that PCVX’s stock grew similarly to BCYC’s over the last 12 months.
PCVX's Price Growth Rating (40) in the null industry is somewhat better than the same rating for BCYC (76). This means that PCVX’s stock grew somewhat faster than BCYC’s over the last 12 months.
BCYC's P/E Growth Rating (27) in the null industry is in the same range as PCVX (58). This means that BCYC’s stock grew similarly to PCVX’s over the last 12 months.
| BCYC | PCVX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | 1 day ago 74% |
| Stochastic ODDS (%) | 1 day ago 81% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 89% | 1 day ago 70% |
| MACD ODDS (%) | 1 day ago 72% | 1 day ago 65% |
| TrendWeek ODDS (%) | 1 day ago 73% | 1 day ago 73% |
| TrendMonth ODDS (%) | 1 day ago 87% | 1 day ago 78% |
| Advances ODDS (%) | 3 days ago 76% | 3 days ago 79% |
| Declines ODDS (%) | 9 days ago 89% | 1 day ago 71% |
| BollingerBands ODDS (%) | 1 day ago 86% | 1 day ago 84% |
| Aroon ODDS (%) | 1 day ago 83% | 1 day ago 76% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BCYC’s FA Score shows that 1 FA rating(s) are green while PCVX’s FA Score has 1 green FA rating(s).
- BCYC’s FA Score: 1 green, 4 red.
- PCVX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BCYC’s TA Score shows that 3 TA indicator(s) are bullish while PCVX’s TA Score has 4 bullish TA indicator(s).
- BCYC’s TA Score: 3 bullish, 6 bearish.
- PCVX’s TA Score: 4 bullish, 6 bearish.
Price Growth
BCYC (@Biotechnology) experienced а +1.71% price change this week, while PCVX (@Biotechnology) price change was -6.40% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
Reported Earning Dates
BCYC is expected to report earnings on Oct 29, 2026.
PCVX is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
BCYC and
Correlation & Price change
A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PCVX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PCVX could also see price increases.
| Ticker / NAME | Correlation To BCYC | 1D Price Change % | ||
|---|---|---|---|---|
| BCYC | 100% | +1.96% | ||
| PCVX - BCYC | 57% Loosely correlated | -0.60% | ||
| RCKT - BCYC | 48% Loosely correlated | +5.00% | ||
| VIR - BCYC | 47% Loosely correlated | -1.32% | ||
| RXRX - BCYC | 46% Loosely correlated | -1.65% | ||
| EDIT - BCYC | 46% Loosely correlated | -0.80% | ||
More | ||||
PCVX and
Correlation & Price change
A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with BCYC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then BCYC could also see price increases.
| Ticker / NAME | Correlation To PCVX | 1D Price Change % | ||
|---|---|---|---|---|
| PCVX | 100% | -0.60% | ||
| BCYC - PCVX | 57% Loosely correlated | +1.96% | ||
| VIR - PCVX | 47% Loosely correlated | -1.32% | ||
| NVAX - PCVX | 45% Loosely correlated | -9.26% | ||
| PTGX - PCVX | 44% Loosely correlated | +1.05% | ||
| CLDX - PCVX | 43% Loosely correlated | -1.36% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RSPH | 39.76 | 0.37 | +0.94% |
| Invesco S&P 500 Equal Weight Health Care ETF (RSPH) | |||
| EUHY | 51.40 | -0.24 | -0.46% |
| iShares Euro High Yield Corporate Bond USD Hedged ETF (EUHY) | |||
| SCHB | 29.33 | -0.36 | -1.21% |
| Schwab U.S. Broad Market ETF (SCHB) | |||
| ASCI | 35.98 | -0.75 | -2.04% |
| Abrdn International Small Cap Active ETF (ASCI) | |||
| RULE | 29.00 | -0.87 | -2.90% |
| Adaptive Core ETF (RULE) | |||